Cerus reported $178.05M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Atrion ATRI:US 133.77M 7.94M
Cerulean Pharma CERU:US $ 48.24M 34.18M
Cerus CERS:US $ 178.05M 7.54M
Cytori Therapeutics CYTX:US $ 22.1M 4.1M
GRIFOLS GRF:SM € 3239.5M 153.93M
Haemonetics HAE:US $ 699.25M 14.88M
Neogen NEOG:US $ 609.12M 17.67M
Nuvasive NUVA:US $ 770.36M 4.61M
Orasure Technologies OSUR:US $ 289.23M 4.18M
Quidel QDEL:US $ 1149.06M 231.38M
Rockwell Medical RMTI:US $ 46.08M 6.32M
Sientra SIEN:US 146.78M 4.76M
Staar Surgical STAA:US $ 263.94M 15.83M
Terumo 4543:JP Y 529532M 18834M
Utah Medical Products UTMD:US $ 75.85M 9.23M